Frontlight ResearchEarly access
Liver and biliary tract cancer trials in China
621 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in ChinaValue of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS
- Where
- Foshan, Guangzhou
- Age
- 18 years to 75 years
- People
- 82
- Run by
- Zhujiang Hospital
See details and how to joinNCT06317896 - Phase 2Taking peopleCombination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Mian XI
See details and how to joinNCT06261125 - Phase 2Taking peopleSingle Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma
- Where
- Xiamen
- Age
- 18 years to 75 years
- People
- 71
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT05970666 - No phaseTaking peopleCryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
- Where
- Guanzhou
- Age
- 18 years to 75 years
- People
- 80
- Run by
- Sun Yat-sen University
See details and how to joinNCT06265350 - Phase 2Taking peopleA Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
- Where
- Beijing, Changsha, Changzhou, Chengdu, Foshan, Fujian, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jiangyin, Jinan, Nanchang, Nanjing, Shanghai, Shenyang, Shijiazhuang, Suzhou, Tianjin, Wuhan, Xi'an, Xuzhou, Yinchuan, Zhengzhou
- Age
- 18 years and over
- People
- 70
- Run by
- Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT05678270 - Phase 2Taking peopleHAIC (Hepatic Artery Infusion Chemotherapy,HAIC)Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma
- Where
- Wuhan
- Age
- 18 years and over
- People
- 38
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06244225 - No phaseTaking peopleApplication of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 100
- Run by
- West China Hospital
See details and how to joinNCT06219096 - Phase 2Taking peoplePhase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
- Where
- Beijing
- Age
- 18 years and over
- People
- 100
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06205472 - No phaseTaking peopleDEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC
- Where
- Beijing, Nanjing
- Age
- 18 years to 80 years
- People
- 188
- Run by
- Zhongda Hospital
See details and how to joinNCT06190665 - Phase 3Taking peopleFOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 200
- Run by
- Sun Yat-sen University
See details and how to joinNCT06201065 - Phase 2Not yet taking people in ChinaA Study of Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma
- Where
- Harbin
- Age
- 18 years to 75 years
- People
- 36
- Run by
- Harbin Medical University
See details and how to joinNCT06196775 - Early phase 1Not yet taking people in ChinaInvestigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer
- Where
- Shenzhen
- Age
- 18 years to 75 years
- People
- 6
- Run by
- BioSyngen Pte Ltd
See details and how to joinNCT06173726 - No phaseNot yet taking people in ChinaEffects of CBT-Based Intervention Among Patients With Liver Cancer
- Where
- Zhuhai
- Age
- 18 years and over
- People
- 160
- Run by
- The Nethersole School of Nursing
See details and how to joinNCT05942560 - Phase 1Taking peopleClinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- Where
- Wuhu
- Age
- 18 years and over
- People
- 60
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06126406 - No phaseTaking peopleMicrowave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
- Where
- Changsha
- Age
- 18 years to 75 years
- People
- 274
- Run by
- Sun Yat-sen University
See details and how to joinNCT05444478 - No phaseNot yet taking people in ChinaObservational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 200
- Run by
- GrandPharma (China) Co., Ltd.
See details and how to joinNCT06079242 - No phaseEnrolling by invitationModified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma
- Where
- Zhanjiang
- Age
- 18 years to 75 years
- People
- 150
- Run by
- Affiliated Hospital of Guangdong Medical University
See details and how to joinNCT06076252 - No phaseTaking peopleStudy on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging
- Where
- Zhuhai
- Age
- 18 years and over
- People
- 1,200
- Run by
- Fifth Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT06060769 - Phase 1Taking peopleA Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 30
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06043466 - Phase 2Not yet taking people in ChinaAdjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 88
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06041490 - No phaseTaking peopleSIRT for Potentially Resectable HCC
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 35
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05994859 - No phaseTaking peopleGPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma
- Where
- Luzhou, Zhuhai
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Chinese Academy of Sciences
See details and how to joinNCT05047510 - Phase 2Not yet taking people in ChinaKN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma
- Where
- Beijing
- Age
- 18 years and over
- People
- 80
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT05985707 - Phase 3Taking peopleSintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 258
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05985798 - Phase 2/3Not yet taking people in ChinaA Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
- Where
- Nanjing, Shanghai
- Age
- 18 years to 75 years
- People
- 668
- Run by
- Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT05976568